Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Tokyo
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

R-Tech Ueno Ltd

+ Add to Watchlist

4573:JP

2,095.0 JPY 95.0 4.75%

As of 01:00:00 ET on 03/04/2015.

Snapshot for R-Tech Ueno Ltd (4573)

Open: 1,980.0 Day's Range: 1,980.0 - 2,095.0 Volume: 132,400
Previous Close: 2,000.0 52wk Range: 945.0 - 2,095.0 1-Yr Rtn: +70.58%

Stock Chart for 4573

No chart data available.
  • 4573:JP 2,095.0
  • 1D
  • 1M
  • 1Y
2,000.0
Interactive 4573 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 4573

Current P/E Ratio (ttm) 40.2962
Estimated P/E(-) -
Relative P/E vs. TPX 2.3090
Earnings Per Share (ttm) 51.9900
Est. EPS -
Est. PEG Ratio -
Market Cap (M JPY) 40,458.64
Shares Outstanding (M) 19.31
30 Day Average Volume 81,553
Price/Book (mrq) 3.6556
Price/Sale (ttm) 7.1231
Dividend Indicated Gross Yield 1.43%
Cash Dividend (JPY) 30.0000
Dividend Ex-Date 03/27/2015
5 Year Dividend Growth 9.00%
Next Earnings Announcement 05/14/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 4573

  • Revenue
  • Net Income (M/JPY)
  • Profit Margin (%)

Company Profile & Key Executives for 4573

R-Tech Ueno Ltd. researches and develops new drugs targeting ophthalmic diseases. The Company manufactures and sells in-house developed eye drops as well as pharmaceutical products for other companies under license contracts. R-Tech Ueno also conducts nonclinical study for pharmaceutical ventures and established companies.

Yukihiko MashimaPresident/CEOTadashi HayashiDirector
More Company Profile & Key Executives for 4573

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil